Sigyn Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Sigyn Therapeutics, Inc. reported Earnings Per Share Diluted of $2.51 (loss) per share for the year ending 2024.

  • Sigyn Therapeutics, Inc. showed an increase of +33.4% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Sigyn Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2022 to 2024), Sigyn Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 19.8%.
  • Historical annual values: Fiscal year 2024: $2.51 (loss) per share | Fiscal year 2023: $3.77 (loss) per share | Fiscal year 2022: $3.13 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: